Is the mean blood leukocyte telomere length a predictor for sporadic thoracic aortic aneurysm? Data from a preliminary study.
暂无分享,去创建一个
C. Balistreri | C. Pisano | K. Fattouch | G. Candore | G. Colonna‐Romano | Daniele Merlo | M. Caruso | E. Incalcaterra
[1] E. Rietzschel,et al. Telomere length and cardiovascular aging: The means to the ends? , 2011, Ageing Research Reviews.
[2] R. Kronmal,et al. Leukocyte telomere length and mortality in the Cardiovascular Health Study. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.
[3] P. van der Harst,et al. Healthy aging and disease: role for telomere biology? , 2011, Clinical science.
[4] A. Mainous,et al. Telomere length as a risk marker for cardiovascular disease: the next big thing? , 2010, Expert review of molecular diagnostics.
[5] L. Rochette,et al. Telomere length and cardiovascular disease. , 2010, Archives of cardiovascular diseases.
[6] N. Samani,et al. Leukocyte Telomere Length is Associated with Abdominal Aortic Aneurysm ( AAA ) , 2010 .
[7] David M. Williams,et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Journal of the American College of Cardiology.
[8] J. Elefteriades,et al. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. , 2010, Journal of the American College of Cardiology.
[9] R. D. de Boer,et al. The emerging role of telomere biology in cardiovascular disease. , 2010, Frontiers in bioscience.
[10] Souvik Sen,et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Circulation.
[11] Magdi H. Yacoub,et al. Cellular and molecular mechanisms of thoracic aortic aneurysms , 2009, Nature Reviews Cardiology.
[12] Nancy E. Adler,et al. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men , 2008, Aging.
[13] S. Stevens,et al. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. , 2008, European heart journal.
[14] Marco Caruso,et al. Pharmacogenomics: a tool to prevent and cure coronary heart disease. , 2007, Current pharmaceutical design.
[15] Guohua Li,et al. Injury prevention and control. , 2007, Emergency medicine clinics of North America.
[16] C. Nienaber,et al. Etiology, pathogenesis and management of thoracic aortic aneurysm , 2007, Nature Clinical Practice Cardiovascular Medicine.
[17] Claudio Franceschi,et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases , 2005, Immunity & Ageing.